title: Does the choice of treatment for type 2 diabetes affect the physiological response to hypoglycemia?
authors.forename: S R
authors.initials: SR
authors.lastname: Peacey
authors.forename: R
authors.initials: R
authors.lastname: Robinson
authors.forename: C
authors.initials: C
authors.lastname: Bedford
authors.forename: N D
authors.initials: ND
authors.lastname: Harris
authors.forename: I A
authors.initials: IA
authors.lastname: Macdonald
authors.forename: R R
authors.initials: RR
authors.lastname: Holman
authors.forename: S R
authors.initials: SR
authors.lastname: Heller
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology*; D005260:Female; D015309:Glucose Clamp Technique; D006801:Humans; D006946:Hyperinsulinism; D007003:Hypoglycemia / Q000139:chemically induced / Q000503:physiopathology*; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007328:Insulin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds